NEW PRECAUTIONS:
There have been reports of congenital abnormalities…a cause and effect relationship has not been established.
There have been post-marketing reports of fetal death…causality has not been determined. Pregnant women receiving anticoagulants, including enoxaparin, are at increased risk for bleeding…and should be carefully monitored.